Senior Director, Artificial Intelligence

About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland. Senior Director, Artificial Intelligence Overview of Role: The Senior Director, Artificial Intelligence (AI) will lead the company's enterprise AI strategy and execution, driving meaningful business outcomes across all corporate functions. As a key strategic leader, this individual will partner with executive leadership and functional experts to identify opportunities where AI can accelerate decision-making, improve operational efficiency, enhance knowledge management, and prepare the organization for commercialization. This role is both visionary and execution-oriented. The Director will define the enterprise AI roadmap, establish governance and best practices, and lead the design and deployment of AI-enabled solutions across functions. Role and Responsibilities: · Partner with the Executive Leadership Team to identify high-value AI opportunities across the organization. · Develop and execute the company's enterprise AI strategy aligned with corporate objectives and key results. · Establish an AI roadmap that prioritizes initiatives based on business impact, feasibility, risk, and organizational readiness. · Partner closely with Research, Clinical Data Management, Biostatistics, Commercial and other business functions to identify opportunities to leverage AI for improving data, processing, analytics, integration, quality, visualization, and competitive insights, and commercial intelligence, accelerating research, clinical development, and evidence-based decision-making across the organization. · Provide technical leadership and guidance to AI resources embedded within business functions through a dotted-line reporting structure. · Build repeatable AI capabilities that can be leveraged across multiple functions. · Partner with IT and external vendors to deploy enterprise-grade AI solutions. · Oversee pilot programs through enterprise-scale implementation. · Build organizational capability through education, training, and AI literacy initiatives. · In conjunction with the head of IT, define policies for model e…